Patents by Inventor Eraldo Antonini

Eraldo Antonini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5206265
    Abstract: The invention relates to an iron citrate micellar complex having a composition of 10.6% carbon, 2.62% hydrogen, 50.2% oxygen, 32% iron, and 4.6% sodium; a molecular weight of about 33,000 (HPLC-LALLS measurement); and the empirical formula (C.sub.31 H.sub.92 O.sub.110 Fe.sub.20 Na.sub.7).sub.n ; to a process for its production; and to its pharmaceutical use.
    Type: Grant
    Filed: March 23, 1992
    Date of Patent: April 27, 1993
    Assignee: Schering Aktiengesellschaft
    Inventors: Hans-Jorg Vidic, Eraldo Antonini, deceased
  • Patent number: 4048305
    Abstract: This invention relates to aseries of tripeptides of the general formula: ##STR1## wherein R = -- H, COCH.sub.3, alkylR.sub.1 = --oh, --nh.sub.2, --nh alkyl (C.sub.1 -C.sub.5) --O alkyl (C.sub.1 -C.sub.5)resulting from condensing of racemic, levorotatory and dextrorotatory phenylalanine and histidine and having an anti-ulcer activity.
    Type: Grant
    Filed: April 8, 1976
    Date of Patent: September 13, 1977
    Assignee: Dr. L. Zambeletti S.p.A.
    Inventors: Luigi Molteni, Gian Piero Vercesi, Eraldo Antonini
  • Patent number: 4029771
    Abstract: A composition for the treatment of bacterial-intestinal infections, especially in infants, containing as an essential ingredient thereof, an effective amount of conalbumen.
    Type: Grant
    Filed: April 21, 1976
    Date of Patent: June 14, 1977
    Inventor: Eraldo Antonini
  • Patent number: 4027012
    Abstract: A process for extracting and isolating from snake venoms the enzymatic component having "in vitro" coagulant activity and "in vivo" anticoagulant activity from the other components having "in vitro" coagulant activity and from the protein components, wherein the snake venom, dissolved in a medium suitable for chromatographic separation treatment is passed through a column filled with a solid support for selective absorption of said in vivo anticoagulant enzyme, not soluble in aqueous solvents, bound to a substratum or inhibitor of said enzyme, a first elution medium at pH 6-7 and molarity less than or equal to 0.05M is passed through said filling, wherein said venom has been introduced, the eluate is collected in subsequent portions until the elution of more than 95% of the protein components of the venom and an "in vitro" coagulant fraction, different from that present in the second eluate are obtained, a second elution medium at a pH even greater than 9 and molarity greater than or equal to 0.
    Type: Grant
    Filed: April 5, 1976
    Date of Patent: May 31, 1977
    Assignee: Laboratori Biochimici Fargal-Pharmasint S.p.A.
    Inventor: Eraldo Antonini
  • Patent number: 3959249
    Abstract: A method for isolating conalbumin as used for strongly interbinding metals, such as iron and copper. According to the method, the white of egg is caused to pass through chelating ions coordinated to metal ions of the transition group at a pH buffered between 3 and 6. Then the mass is caused to pass through an active component for the conalbumin-metal complex, the conalbumin being finally isolated therefrom.
    Type: Grant
    Filed: October 24, 1974
    Date of Patent: May 25, 1976
    Assignee: Officina Terapeutica Italiana O.T.I. Laboratorio Biologico S.p.A.
    Inventor: Eraldo Antonini